Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Pragya, Misra"'
Autor:
Pragya Misra, Shailza Singh
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 1976-1995 (2019)
Abstract Lung cancer is the leading cause of deaths related to cancer and accounts for more than a million deaths per year. Various new strategies have been developed and adapted for treatment; still the survival for 5 years is just 16% in patients w
Externí odkaz:
https://doaj.org/article/19733afa175e4cd9a5ff1a9b2380dc86
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 12, Iss 4, Pp 1771-1782 (2018)
Containment/dissemination of Leishmaniasis depends on the dominance of Th1/ Th2 immunity. IFN-γ and IL-17A are well known for protection from leishmaniasis. Synergistic effects of these two cytokines are also known in various autoimmune diseases.
Externí odkaz:
https://doaj.org/article/a0c2c71f2c514f5a8ece151aa0c722a0
Autor:
Rakesh Kumar Deepak, Divya Kamboj, Dipendra Kumar Mitra, Abhinav Saurabh, Umesh Gupta, Rati Tandon, Pragya Misra, Anant Mohan, Randeep Guleria, Girija Mehta, Prabin Kumar, Deepshi Thakral, Mandira Varma Basil, Pushpa Gupta, Anuj Bhatnagar
Publikováno v:
European Journal of Immunology. 50:736-747
Prolonged therapy, drug toxicity, noncompliance, immune suppression, and alarming emergence of drug resistance necessitate the search for therapeutic vaccine strategies for tuberculosis (TB). Such strategies ought to elicit not only IFN-γ, but polyf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c50be21912e549d36b79835b20f06e2
https://doi.org/10.1002/eji.201948283
https://doi.org/10.1002/eji.201948283
Publikováno v:
Systems Biomedicine Approaches in Cancer Research ISBN: 9789811919527
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5726d724813beab3dcfe8c6f380d14f6
https://doi.org/10.1007/978-981-19-1953-4_1
https://doi.org/10.1007/978-981-19-1953-4_1
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 12, Iss 4, Pp 1771-1782 (2018)
Containment/dissemination of Leishmaniasis depends on the dominance of Th1/ Th2 immunity. IFN-γ and IL-17A are well known for protection from leishmaniasis. Synergistic effects of these two cytokines are also known in various autoimmune diseases. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d59c33bf0788470fe5a7d4a0edeabc7
https://microbiologyjournal.org/adjunct-therapy-of-rifn-g-and-ril-17a-along-with-sub-optimal-dose-of-amphotericin-b-effectively-control-the-leishmania-donovani-parasitic-growth-in-infected-mice/
https://microbiologyjournal.org/adjunct-therapy-of-rifn-g-and-ril-17a-along-with-sub-optimal-dose-of-amphotericin-b-effectively-control-the-leishmania-donovani-parasitic-growth-in-infected-mice/
Publikováno v:
Current Problems in Cancer
In the unprecedented times of Corona Pandemic (CP), each individual is facing uncertainty and stress. Presence of cancer during these times compounds the troubles. The changing scenario of consultation and treatment during pandemic, logistic issues,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c37e9bc06276371f5d2afc04412a5da7
http://europepmc.org/articles/PMC7669237
http://europepmc.org/articles/PMC7669237
Autor:
Pragya Misra, Shailza Singh
Publikováno v:
Metagenomic Systems Biology ISBN: 9789811585616
Gut microbiota with diverse population has gained a lot of attention in the last decade. This microbial population along with maintaining homeostasis in gut also shapes the immune system in gut by interacting with various arms of the immune system. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01b30b3c74f5d9cb508005611991c581
https://doi.org/10.1007/978-981-15-8562-3_1
https://doi.org/10.1007/978-981-15-8562-3_1
Autor:
Shailza Singh, Pragya Misra
Publikováno v:
Systems and Synthetic Immunology ISBN: 9789811533495
Leishmaniasis is a neglected tropical disease subverting the immune system of the infected individual. Most of available treatment regimens are associated with various drawbacks such as drug resistance, toxicity, and cost. Development and implementat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25590c64e38f801d8c6d9c6d6f6a0b88
https://doi.org/10.1007/978-981-15-3350-1_1
https://doi.org/10.1007/978-981-15-3350-1_1
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e30746 (2012)
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi and L. infantum is characterized by defective cell-mediated immunity (CMI) and is usually fatal if not treated properly. An estimated 350 million people
Externí odkaz:
https://doaj.org/article/a52d83da76cb42778005621f17f605b4
Autor:
Dipendra Kumar Mitra, Pragya Misra, Prabin Kumar, Abhinav Saurabh, Chandreshwar Prasad Thakur, Narayan Rishi
Publikováno v:
Clinical and Experimental Immunology. 191:318-327
Summary Visceral leishmaniasis (VL) is a disseminated and lethal disease of reticulo-endothelial system caused by protozoan parasites Leishmania donovani and L. infantum, which are known to induce host T cell suppression. To understand the impact of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec704ba0db334fcb77188731db23847a
https://doi.org/10.1111/cei.13074
https://doi.org/10.1111/cei.13074